RK
Robyn Karnauskas Truist Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Gilead Sciences
GILD
$143B
| $115.05 | $73 |
37%
downside
| Hold | 5 years ago |
|
27
Biogen
BIIB
$20.6B
| $140.67 | $330 |
135%
upside
| Buy | 5 years ago |
|
28
Arcus Biosciences
RCUS
$1.3B
| $12.19 | $22 |
80%
upside
| Buy | 5 years ago |
|
29
Immunovant
IMVT
$2.99B
| $17.14 | $24 |
40%
upside
| Buy | 5 years ago |
|